Latest issue of Clinical laboratory
November 2025
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
SeraNovo and Ildong Pharmaceutical to collaborate on research projects
, /in E-News /by panglobalSeraNovo (Leiden, The Netherlands) has closed a multi compound deal with Ildong Pharmceutical (Seoul, South Korea), a pharmaceutical company engaged in the research and development of small molecules in the field of neuroscience and oncology.
Capitainer collaborates with Timothy Garrett Lab to accelerate method development for implementation of Capitainer’s qDBS sampling
, /in E-News /by panglobalSwedish medtech start-up Capitainer has entered a collaboration agreement with Timothy J. Garrett Laboratory, College of Medicine, University of Florida. Dr Tim Garrett is one of the leading experts and an authority in the US when it comes to applying mass spectrometry within the area of metabolomics and its clinical applications.
Newly launched Absolute Biotech integrates multiple brands to offer antibody reagents, services to researchers worldwide
, /in E-News /by panglobalAbsolute Biotech was launched on October 4, 2022 as a unified company joining together leading antibody-centric brands from around the world. Absolute Biotech specializes in antibody reagents and services, adding value to existing antibodies, reagents and kits through annotation, validation, sequencing, engineering and recombinant manufacturing. The combined company will leverage each brand’s unique antibody expertise […]
MEDICA | DÜSSELDORF, GERMANY 14-17 NOVEMBER 2022
, /in Advertenties /by panglobalPROCALCITONIN FS
, /in Advertenties /by panglobalNew developments in LC-MS/MS
, /in Featured Articles /by panglobalIn their aim to support researchers and clinicians, companies such as Thermo Fisher Scientific are also at the forefront of their own R&D. CLI caught up with Dr Edward Goucher, Senior Manager of Business Development, to discuss their new developments.
Analysis of illicit drugs in purchased and seized electronic cigarette liquids from the United Kingdom 2014-2021
, /in Featured Articles /by panglobalFrinculescu A, Coombes G, Shine T et al. Drug Test Anal 2022;doi:10.1002/dta.3277 Increasing popularity and known shortfalls in the regulation of electronic cigarettes (ECs) emphasizes the urgent need for closer content monitoring and for comprehensible information on their possible health effects.
Diagnostic value of combined detection of tumour markers for 143 cases of primary hepatic carcinoma
, /in Featured Articles, Tumour Markers /by panglobalby Xijun Min, Dr Yan Li, Liuyan Chen, Chengwei Yao, Dr Xi Qin As a traditional tumour marker for the diagnosis of early primary hepatic carcinoma (PHC), alpha fetoprotein (AFP) has a low positive rate. Serum glypican 3 (GPC3) is a novel biomarker, and the combined examination of GPC3 and AFP will provide a new […]
The Intelligent Analyzer
, /in Advertenties /by panglobalUrinary ALCAM as a biomarker for lupus nephritis
, /in Featured Articles /by panglobalby Dr Cherie Ng and Dr Chaim Putterman Lupus nephritis is an immune-mediated glomerulonephritis that causes significant morbidity and mortality in patients with systemic lupus erythematous, a multisystem autoimmune disease. Non-invasive biomarkers are necessary to track disease and treatment response. Urinary ALCAM is a potential biomarker that samples the kidney and is relevant to the […]